1
|
Ledford H. How Dolly the sheep's legacy lives on: CRISPR cattle and cloned camels. Nature 2023; 622:18-19. [PMID: 37749340 DOI: 10.1038/d41586-023-02921-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/27/2023]
|
2
|
Sheehan M. The role of emotion in ethics and bioethics: dealing with repugnance and disgust. J Med Ethics 2016; 42:1-2. [PMID: 26671164 DOI: 10.1136/medethics-2015-103294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|
3
|
Abstract
BACKGROUND Extant surveys of people's attitudes towards human reproductive cloning focus on moral judgements alone, not emotional reactions or sentiments. This is especially important given that some (especially Leon Kass) have argued against such cloning on the ground that it engenders widespread negative emotions, like disgust, that provide a moral guide. OBJECTIVE To provide some data on emotional reactions to human cloning, with a focus on repugnance, given its prominence in the literature. METHODS This brief mixed-method study measures the self-reported attitudes and emotions (positive or negative) towards cloning from a sample of participants in the USA. RESULTS Most participants condemned cloning as immoral and said it should be illegal. The most commonly reported positive sentiment was by far interest/curiosity. Negative emotions were much more varied, but anxiety was the most common. Only about a third of participants selected disgust or repugnance as something they felt, and an even smaller portion had this emotion come to mind prior to seeing a list of options. CONCLUSIONS Participants felt primarily interested and anxious about human reproductive cloning. They did not primarily feel disgust or repugnance. This provides initial empirical evidence that such a reaction is not appropriately widespread.
Collapse
|
4
|
Mackowiak PA. President's address: Mary Shelley, Frankenstein, and the dark side of medical science. Trans Am Clin Climatol Assoc 2014; 125:1-13. [PMID: 25125714 PMCID: PMC4112683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- Philip A. Mackowiak
- Correspondence and reprint requests: Philip A. Mackowiak, MD,
Medical Service-111, VA Medical Center, 10 N. Greene St., Baltimore, MD 21201410-605-7199
| |
Collapse
|
5
|
Abstract
One of the most influential philosophers of the 20th century, Martin Heidegger (1889-1976), died prior to the remarkable cloning of the sheep Dolly and before Dr. Venter started his experiments on creating synthetic life, and he never explicitly discussed living technologies. However, by reinterpreting his notion of "modern technology," this article shows how it is possible to philosophically assess living technologies and to recognize ways in which Heidegger anticipated this phenomenon with his notion of cybernetics. The interpretation elucidates the fundamental process of technology becoming living and simultaneously presents living technology as the ultimate technology. The thesis of this article is that living technology is not just one more technology; rather, it is the perfection of technology as understood by Aristotle. Aristotle's thinking is in this way a key example of a profound reassessment of nature and technology. Aristotle clearly separates these two domains of being in his definition, but in doing so, he also connects them to one another in a highly influential way. Following this line of thought, the article finally offers an original perspective involving renewed respect for the perpetual self-unfolding nature of living technology.
Collapse
|
6
|
Mauron A. [Caffe lungo]. Rev Med Suisse 2013; 9:1234. [PMID: 23798196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Affiliation(s)
- Alexandre Mauron
- Institut d' éthique biomédicale, Centre Médicale Universitaire, Genéve.
| |
Collapse
|
7
|
Nau JY. [Very uncertain return of human cloning]. Rev Med Suisse 2013; 9:1172-1173. [PMID: 23789189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
|
8
|
Coulombel L. [Somatic cell nuclear transfer in human ovocytes]. Med Sci (Paris) 2012; 28:365-7. [PMID: 22549861 DOI: 10.1051/medsci/2012284011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
9
|
Aloni E. Cloning and the LGBTI family: cautious optimism. Rev Law Soc Change 2011; 35:1-80. [PMID: 21774156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Affiliation(s)
- Erez Aloni
- University of Pennsylvania Law School, USA
| |
Collapse
|
10
|
Lewis JL. Predicting the judicial response to an asserted right to reproductive cloning. J Leg Med 2008; 29:523-536. [PMID: 19023779 DOI: 10.1080/01947640802494853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
|
11
|
Shaw DM. Moral qualms, future persons, and embryo research. Bioethics 2008; 22:218-223. [PMID: 18405320 DOI: 10.1111/j.1467-8519.2008.00639.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Many people have moral qualms about embryo research, feeling that embryos must deserve some kind of protection, if not so much as is afforded to persons. This paper will show that these qualms serve to camouflage motives that are really prudential, at the cost of also obscuring the real ethical issues at play in the debate concerning embryo research and therapeutic cloning. This in turn leads to fallacious use of the Actions/Omissions Distinction and ultimately neglects the duties that we have towards future persons.
Collapse
|
12
|
Tamashiro KLK, Sakai RR, Yamazaki Y, Wakayama T, Yanagimachi R. Developmental, behavioral, and physiological phenotype of cloned mice. Adv Exp Med Biol 2007; 591:72-83. [PMID: 17176555 DOI: 10.1007/978-0-387-37754-4_5] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Cloning from adult somatic cells has been successful in at least ten species. Although generating viable cloned mammals from adult cells is technically feasible, prenatal and perinatal mortality is high and live cloned offspring have had health problems. This chapter summarizes the health consequences of cloning in mice and discusses possible mechanisms through which these conditions may arise. These studies have further significance as other assisted reproductive techniques (ART) also involve some of the same procedures used in cloning, and there are some reports that offspring generated by ART display aberrant phenotypes as well. At the moment, the long-term consequences of mammalian cloning remain poorly characterized. Data available thus far suggest that we should use this technology with great caution until numerous questions are addressed and answered.
Collapse
Affiliation(s)
- Kellie L K Tamashiro
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 618, Baltimore, Maryland 21205, USA.
| | | | | | | | | |
Collapse
|
13
|
Affiliation(s)
- Lyle Armstrong
- Centre For Stem Cell Biology and Developmental Genetics, University of Newcastle, International Centre for Life, Central Parkway, UK.
| | | |
Collapse
|
14
|
Abstract
The topic of this review is an alternative technique for somatic cell nuclear transfer. Removal of the zona pellucida facilitates manipulations of mammalian oocytes and early embryos, and problems related to their subsequent culture are commonly overestimated. This approach enables radical modifications to somatic cell nuclear transfer, and the handmade cloning (HMC) technique is now successfully applied to an increasing numbers of species. HMC radically decreases costs and the need for a skilled workforce; furthermore, it increases productivity, enables cryopreservation, and results in birth rates comparable, or even higher, than those achievable by micromanipulation-based traditional cloning (TC). The new technique can accelerate technology transfer and standardization and, eventually, might contribute to the widespread application of cloning. Additionally, HMC offers unique possibilities for the automation of somatic cell nuclear transfer.
Collapse
Affiliation(s)
- Gábor Vajta
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, DK-8830 Tjele, Denmark.
| |
Collapse
|
15
|
Abstract
When confronted by pressure from activists and Congress, the US Food and Drug Administration (FDA) has not always adopted policies and made decisions about individual products that accord with the scientific evidence. An example was the unnecessarily and markedly prolonged review of the veterinary drug bovine somatotropin (bST), or bovine growth hormone, during the 1980s. The FDA now faces a similar situation surrounding the question of whether meat and milk from cloned animals and their offspring are safe for human consumption. Having made a preliminary decision in the affirmative - based on an exhaustive analysis of scientific articles, health records, blood samples and studies of the composition of meat and milk - the agency has been beleaguered by criticisms. It remains to be seen whether, ultimately, science will trump anti-technology, anti-consumer activism.
Collapse
Affiliation(s)
- Henry I Miller
- The Hoover Institution, Stanford University, Stanford, CA 94305-6010, USA.
| |
Collapse
|
16
|
Abstract
Attempts through somatic cell nuclear transfer to expand wild populations that have shrunk to critical numbers is a logical extension of the successful cloning of mammals. However, although the first mammal was cloned 10 years ago, nuclear reprogramming remains phenomenological, with abnormal gene expression and epigenetic deregulation being associated with the cloning process. In addition, although cloning of wild animals using host oocytes from different species has been successful, little is known about the implication of partial or total mitochondrial DNA heteroplasmy in cloned embryos, fetuses and offspring. Finally, there is a need for suitable foster mothers for inter-intra specific cloned embryos. Considering these issues, the limited success achieved in cloning endangered animals is not surprising. However, optimism comes from the rapid gain in the understanding of the molecular clues underlying nuclear reprogramming. If it is possible to achieve a controlled reversal of the differentiated state of a cell then it is probable that other issues that impair the cloning of endangered animals, such as the inter-intra species oocyte or womb donor, will be overcome in the medium term.
Collapse
Affiliation(s)
- Pasqualino Loi
- Department of Comparative Biomedical Sciences, Piazza Aldo Moro 45, 64100, Teramo, Italy.
| | | | | |
Collapse
|
17
|
Abstract
There is a constant expectation for fast improvement of livestock production and human health care products. The advent of DNA recombinant technology and the possibility of gene transfer between organisms of distinct species, or even distinct phylogenic kingdoms, has opened a wide range of possibilities. Nowadays we can produce human insulin in bacteria or human coagulation factors in cattle milk. The recent advances in gene transfer, animal cloning, and assisted reproductive techniques have partly fulfilled the expectation in the field of livestock transgenesis. This paper reviews the recent advances and applications of transgenesis in livestock and their derivative products. At first, the state of art and the techniques that enhance the efficiency of livestock transgenesis are presented. The consequent reduction in the cost and time necessary to reach a final product has enabled the multiplication of transgenic prototypes around the world. We also analyze here some emerging applications of livestock transgenesis in the field of pharmacology, meat and dairy industry, xenotransplantation, and human disease modeling. Finally, some bioethical and commercial concerns raised by the transgenesis applications are discussed.
Collapse
Affiliation(s)
- Eduardo O Melo
- EMBRAPA Genetic Resources and Biotechnology, Av. W/5, Norte Final, PBI, Sala 7B, Brasilia, DF, Brazil, CEP 70770-900.
| | | | | | | |
Collapse
|
18
|
|
19
|
|
20
|
|
21
|
Abstract
The recent successes in producing cloned offspring by somatic cell nuclear transfer are nothing short of remarkable. This process requires the somatic cell chromatin to substitute functionally for both the egg and the sperm genomes, and indeed the processing of the transferred nuclei shares aspects in common with processing of both parental genomes in normal fertilized embryos. Recent studies have yielded new information about the degree to which this substitution is accomplished. Overall, it has become evident that multiple aspects of genome processing and function are aberrant, indicating that the somatic cell chromatin only infrequently manages the successful transition to a competent surrogate for gamete genomes. This review focuses on recent results revealing these limitations and how they might be overcome.
Collapse
Affiliation(s)
- Keith E Latham
- The Fels Institute for Cancer Research and Molecular Biology, Department of Biochemistry, 3307 North Broad Street, Philadelphia, Pennsylvania 19140, USA.
| | | | | |
Collapse
|
22
|
Abstract
Somatic cell nuclear transfer (SCNT) is much more widely and efficiently practiced in cattle than in any other species, making this arguably the most important mammal cloned to date. While the initial objective behind cattle cloning was commercially driven--in particular to multiply genetically superior animals with desired phenotypic traits and to produce genetically modified animals-researchers have now started to use bovine SCNT as a tool to address diverse questions in developmental and cell biology. In this paper, we review current cattle cloning methodologies and their potential technical or biological pitfalls at any step of the procedure. In doing so, we focus on one methodological parameter, namely donor cell selection. We emphasize the impact of epigenetic and genetic differences between embryonic, germ, and somatic donor cell types on cloning efficiency. Lastly, we discuss adult phenotypes and fitness of cloned cattle and their offspring and illustrate some of the more imminent commercial cattle cloning applications.
Collapse
Affiliation(s)
- Björn Oback
- Björn Oback-Reproductive Technologies, AgResearch Ltd., Ruakura Research Centre, East Street, Private Bag 3123, Hamilton, New Zealand.
| | | |
Collapse
|
23
|
Abstract
In all animal species, initiation of embryonic development occurs shortly after the joining together of the gametes from each of the sexes. The first of these steps, referred to as "egg activation", is a series of molecular events that results in the syngamy of the two haploid genomes and the beginning of cellular divisions for the new diploid embryo. For many years it has been known that the incoming sperm drives this process, as an unfertilized egg will remain dormant until it can no longer sustain normal metabolic processes. Until recently, it was also believed that the sperm was the only cell capable of creating a viable embryo and offspring. Recent advances in cell biology have allowed researchers to not only understand the molecular mechanisms of egg activation, but to exploit the use of pharmacological agents to bypass sperm-induced egg activation for the creation of animals by somatic cell nuclear transfer. This chapter will focus on the molecular events of egg activation in mammals as they take place during fertilization, and will discuss how these mechanisms are successfully bypassed in processes such as somatic cell nuclear transfer.
Collapse
Affiliation(s)
- Christopher Malcuit
- Department of Veterinary and Animal Sciences, Paige Laboratory, University of Massachusetts, Amherst, Massachusetts 01003, USA
| | | |
Collapse
|
24
|
Abstract
Although it has now been 10 years since the first cloned mammals were generated from somatic cells using nuclear transfer (NT), most cloned embryos usually undergo developmental arrest prior to or soon after implantation, and the success rate for producing live offspring by cloning remains below 5%. The low success rate is believed to be associated with epigenetic errors, including abnormal DNA hypermethylation, but the mechanism of "reprogramming" is unclear. We have been able to develop a stable NT method in the mouse in which donor nuclei are directly injected into the oocyte using a piezo-actuated micromanipulator. Especially in the mouse, only a few laboratories can make clones from adult somatic cells, and cloned mice are never successfully produced from most mouse strains. However, this technique promises to be an important tool for future research in basic biology. For example, NT can be used to generate embryonic stem (NT-ES) cell lines from a patient's own somatic cells. We have shown that NT-ES cells are equivalent to ES cells derived from fertilized embryos and that they can be generated relatively easily from a variety of mouse genotypes and cell types of both sexes, even though it may be more difficult to generate clones directly. In general, NT-ES cell techniques are expected to be applied to regenerative medicine; however, this technique can also be applied to the preservation of genetic resources of mouse strain instead of embryos, oocytes and spermatozoa. This review describes how to improve cloning efficiency and NT-ES cell establishment and further applications.
Collapse
|
25
|
Abstract
It is now more than nine years since Dolly, the world's first somatic cell cloned mammal was born, and the success of somatic cell nuclear transfer (SCNT) is still disappointingly low. Only about 3-5% of reconstructed embryos develop to term, and it is also evident that even if some clones are born, they are not necessarily fully developed and healthy. Embryonic and neonatal abnormalities of cloned offspring are probably a result of incorrect or incomplete reprogramming of the transferred donor cell nuclei. Such an incomplete reprogramming reflects the extremely low efficiency of SCNT. The key role in the process of reprogramming has been attributed to the enucleated oocyte-cytoplast into which the somatic cell nucleus is transferred. In our chapter, we will discuss the methodological approaches used for the preparation of cytoplasts and their possible reprogramming activities.
Collapse
Affiliation(s)
- Josef Fulka
- Institute of Animal Production, POB 1, CS-104 01 Prague 10, Czech Republic.
| | | |
Collapse
|
26
|
Suk J, Bruce A, Gertz R, Warkup C, Whitelaw CBA, Braun A, Oram C, Rodríguez-Cerezo E, Papatryfon I. Dolly for dinner? Assessing commercial and regulatory trends in cloned livestock. Nat Biotechnol 2007; 25:47-53. [PMID: 17211395 DOI: 10.1038/nbt0107-47] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
As cloning technologies become more widely established, will products enter the food chain sooner than regulatory agencies and the public might be prepared for?
Collapse
Affiliation(s)
- J Suk
- ESRC Genomics Policy & Research Forum, University of Edinburgh, St. John's Land, Edinburgh, Scotland
| | | | | | | | | | | | | | | | | |
Collapse
|
27
|
|
28
|
|
29
|
Nau JY. [The year 2006, between cloning and gene doping]. Rev Med Suisse 2006; 2:2073. [PMID: 17019845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
|
30
|
Kessler JA. Stem cell potential remains unchanged. Nat Clin Pract Neurol 2006; 2:231. [PMID: 16932554 DOI: 10.1038/ncpneuro0174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
31
|
One of a kind: what did Dolly the sheep really do for us? New Sci 2006; 191:5. [PMID: 17111515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
|
32
|
Aldhous P, Coghlan A. Therapeutic cloning set back by hype and fraud. New Sci 2006; 191:11. [PMID: 17111517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
|
33
|
Aldhous P, Coghlan A. Ten years on, has the cloning dream died? New Sci 2006; 191:8-10. [PMID: 17111516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
|
34
|
|
35
|
Abstract
The recent desperation to clone human embryos may be seriously undermining accepted ethical principles of medical research, with potentially profound wider consequences
Collapse
Affiliation(s)
- N Cobbe
- Wellcome Trust Centre for Cell Biology, University of Edinburgh, Michael Swann Building, King's Buildings, Mayfield Road, Edinburgh EH9 3JR, UK.
| |
Collapse
|
36
|
Abstract
The development and transplantation of autologous cells derived from nuclear transfer embryonic stem cell (NT-ESC) lines to treat patients suffering from disease has been termed therapeutic cloning. Human NT is still a developing field, with further research required to improve somatic cell NT and human embryonic stem cell differentiation to deliver safe and effective cell replacement therapies. Furthermore, the implications of transferring mitochondrial heteroplasmic cells, which may harbor aberrant epigenetic gene expression profiles, are of concern. The production of human NT-ESC lines also remains plagued by ethical dilemmas, societal concerns, and controversies. Recently, a number of alternate therapeutic strategies have been proposed to circumvent the moral implications surrounding human nuclear transfer. It will be critical to overcome these biological, legislative, and moral restraints to maximize the potential of this therapeutic strategy and to alleviate human disease.
Collapse
Affiliation(s)
- Vanessa J Hall
- Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Centre, Lund University, Sweden.
| | | | | |
Collapse
|
37
|
Affiliation(s)
- Robert Pijnenborg
- Department of Gynaecology and Obstetrics, Universitair Ziekenhuis Gasthuisberg, Katholieke Universiteit Leuven, BE-3000 Leuven, Belgium.
| |
Collapse
|
38
|
Doerflinger RM. The many casualties of cloning. New Atlantis 2006; 12:60-70. [PMID: 16832955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
|
39
|
Rey del Castillo J. [The status of human cloning in the international setting]. Rev Derecho Genoma Hum 2006:185-210. [PMID: 17124976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
The General Assembly of the United Nations submitted a Declaration on Human Cloning in March 2005. The text of such Declaration was the result of a difficult and long process, taking more than three years. Being a Declaration instead of a Resolution, it has not legal capability in inforcing United Nations members to act according to its recommendations. This article begins with an explanation of several terms referred to cloning. Different countries' legislation on cloning is analyzed. Positions of the same countries at the Convention of the United Nations are as well analyzed. Comparing both countries' views shows that national legislation on cloning is independent and orientated by some countries' particular interests and biological and ethical views on these issues. Future developments on human cloning and its applications will be shared among all countries, both the ones currently allowing and supporting "therapeutic" cloning and the ones now banning it. In such case, it would be important to reach agreements on these issues at an international level. The article discusses possible legislative developments and offers some proposals to reach such agreements.
Collapse
|
40
|
Joshi SR. Stem cell medicine--2006. J Assoc Physicians India 2006; 54:13-4. [PMID: 16649732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
|
41
|
Human cloning and scientific corruption: the South Korea scandal and the future of the stem cell debate. New Atlantis 2006; 11:113-7. [PMID: 16789313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
|
42
|
Abstract
The birth of viable offspring from somatic cell nuclear transfer (SCNT) in mammals caused a major re-examination of the understanding of the commitment of cells to specific tissue lineages during differentiation. The questions of whether cells undergo dedifferentiation or transdifferentiation during the development of offspring and how these changes are controlled is a source of ongoing debate that is yet to be resolved. Irrespective of the outcome of this debate, it is clear that cloning using SCNT has a place and purpose in the future of research and animal breeding. The future uses of SCNT could include the production of transgenic mice, the production of transgenic livestock and assisting with the re-establishment of endangered species. Human medicine also would benefit from future use of SCNT because it would allow the production of patient-specific embryonic stem cells.
Collapse
Affiliation(s)
- Alan O Trounson
- Monash Immunology and Stem Cell Laboratories, Monash University, Melbourne, Victoria, Australia
| |
Collapse
|
43
|
|
44
|
Bürger J. [Embryonic stem cells from patients with incurable diseases are successfully cloned]. Versicherungsmedizin 2005; 57:196-7. [PMID: 16392384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
|
45
|
|
46
|
Abstract
Transgenic animal technology is one of the most fascinating technologies developed in the last two decades. It allows us to address questions in life sciences that no other methods have achieved. The impact on biomedical and biological research, as well as commercial interests are overwhelming. The questions accompanying this fast growing technology and its diversified applications attract the attention from a variety of entities. Still, one of the most fundamental problems remaining is the search for an efficient and reliable gene delivery system for creating transgenic animals. The traditional method of pronuclear microinjection has displayed great variability in success among species. While an acceptable efficiency in the production of transgenic mice has been attained, the relative low efficiency (<1%) in creating transgenic livestock has become one of the barriers for its application. In the past decades, improvements in producing transgenic livestock have made a slow progression, however, the recent advancement in cloning technology and the ability to create transgenic livestock in a highly efficient manner, have opened the gate to a new era in transgenic technology. Discoveries of new gene delivery systems have created an enthusiastic atmosphere that has made this technology so unique. This review focuses on gene delivery strategies as well as various approaches that may assist the advancement of transgenic efficiency in large animals.
Collapse
Affiliation(s)
- A W Chan
- Oregon Regional Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon 97006, USA.
| |
Collapse
|
47
|
Nau JY. [Seoul, first world capital of human cloning]. Rev Med Suisse 2005; 1:2554. [PMID: 16323740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
|
48
|
|
49
|
Kolata G. Beating hurdles, scientists clone a dog for a first. N Y Times Web 2005:A1, A10. [PMID: 16134270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
|
50
|
Abstract
It is now 8 years since the birth of Dolly, the first animal produced by nuclear transfer using a donor cell population established from an adult animal. During this time, the technique of nuclear transfer has been successfully applied to a range of mammalian species for the production of offspring using a plethora of donor cell types derived from both foetal and adult tissues. In addition, when coupled with genetic manipulation of the donor cells, transgenic offspring have been produced with a range of genetic modifications including gene knockouts and gene knockings. Despite the apparent successes of the technology, the efficiency of development to live offspring has remained low and developmental abnormalities still occur. The objectives of this paper are to review some of the successes and failures of the nuclear transfer procedure since the production of Dolly. In particular, we will review the major steps in the procedure and discuss studies from our laboratory and others which have modified the procedure in ways which may impact on development.
Collapse
Affiliation(s)
- K H S Campbell
- Animal Development and Biotechnology Group, Division of Animal Physiology, University of Nottingham, School of Biosciences, Sutton Bonington, Loughborough, Leics LE12 5RD, UK.
| | | | | | | | | | | | | |
Collapse
|